Iowa House Bill HF1049

Iowa 2025-2026 Regular Session

• Introduced: 5/12/25
• Engrossed: 5/13/25
• Enrolled: 5/22/25
• Passed: 6/11/25

Caption

A bill for an act relating to and making appropriations to the department of veterans affairs and the department of health and human services, and related provisions and appropriations, including aging and disability services; behavioral health, public health, community access and eligibility; the medical assistance program, state supplementary assistance, Hawki, and other health-related programs; sex reassignment surgeries or associated procedures; family well-being and protection; state-operated specialty care, administration and compliance; transfers, cash flows, and nonreversions; prior appropriations; the beer and liquor control fund, and the behavioral health fund; report on nonreversion of moneys; emergency rules; and a hospital directed payment program; and including effective date and retroactive applicability provisions. (Formerly HSB 342.) Effective date: 06/11/2025, 07/01/2025. Applicability date: 07/01/2024.

Summary

House File 1049 is a large appropriations and policy bill for fiscal year 2025-2026 that funds the Iowa Department of Veterans Affairs and a wide range of Department of Health and Human Services programs. It provides operating money for veterans services and the Iowa Veterans Home, aging and disability services, behavioral health, public health, community access and eligibility, child support services, TANF-related programs, Medicaid and Hawki, health program operations, child protective services, state-operated specialty care, and administrative/compliance functions. The bill also includes targeted funding for items such as rural psychiatric residencies, free clinics, radon test kits, child care assistance, early childhood and family support programs, adoption subsidies, foster care and child welfare services, and a new hospital directed payment program. Beyond appropriations, the bill makes several substantive changes to state law and program administration. It creates a new prohibition on Medicaid reimbursement for sex reassignment surgery and associated procedures, including hormone therapy and other gender-affirming medical interventions tied to a gender dysphoria diagnosis. It also raises the personal needs allowance for certain Medicaid residents from $50 to $55 per month, directs HHS to develop new nursing facility reimbursement and bed-forecasting methodologies, authorizes nonreversion and transfer provisions for various funds, and requires quarterly or monthly reporting in several areas. The bill further amends the beer and liquor control fund transfer structure related to behavioral health funding and establishes a framework for a hospital directed payment program subject to federal approval. The general sentiment reflected in the voting history appears to be supportive of the bill overall, but not unanimously so. The bill passed both chambers, with the House voting 63-28 and the Senate voting 31-14 on passage, indicating majority support but meaningful opposition. The repeated passage votes suggest the bill was a major budget vehicle that ultimately advanced despite partisan or policy disagreements. The main points of contention appear to center on the social policy provisions and the size and direction of health and human services spending. The prohibition on Medicaid reimbursement for sex reassignment-related care is likely the most controversial policy change and would be expected to draw opposition from supporters of transgender health care access. Other possible areas of disagreement include the abortion-related language limiting Medicaid reimbursement, the pregnancy prevention grant requirements emphasizing abstinence, and the bill’s extensive use of fund transfers, nonreversion authority, and administrative flexibility. Supporters likely viewed the bill as necessary to fund core health, child welfare, and veterans programs while also tightening oversight and aligning spending with state priorities.

Impact

HF 1049 appropriates state and special-fund dollars across veterans affairs and HHS programs for FY 2025-2026 and amends multiple provisions in the Iowa Code and prior appropriations acts. It affects statutes governing Medicaid, Hawki, child welfare, child support, behavioral health funding, nursing facility reimbursement, personal needs allowances, and a new hospital directed payment program, while also authorizing transfers, nonreversions, emergency rulemaking, and retroactive application to July 1, 2024 for selected provisions. Affected parties include veterans, older adults, people with disabilities, Medicaid recipients, children and families involved in child welfare or child care systems, health care providers, hospitals, and HHS-administered service providers and contractors.

Sentiment

The bill’s overall sentiment was broadly favorable enough to pass both chambers, suggesting lawmakers viewed it as an essential budget and policy package for health and human services. At the same time, the recorded floor votes show substantial minority opposition, indicating that several provisions were politically divisive even within a must-pass appropriations framework. The bill’s support appears strongest around funding continuity for core services, while opposition likely concentrated on the bill’s social policy restrictions and administrative controls.

Contention

The most notable contention is the new Medicaid reimbursement prohibition for sex reassignment surgeries and associated procedures, which is a direct policy restriction rather than a funding decision and is likely to be opposed by advocates for transgender health care. Additional friction points include the abortion-related Medicaid language, the abstinence-focused pregnancy prevention grant requirements, and the bill’s use of broad transfer and nonreversion authority, which can reduce legislative control over spending. There may also have been disagreement over the hospital directed payment program and the extent to which the bill shifts costs, imposes assessments, or relies on federal approval and future rulemaking.